Concepts (301)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipose Tissue | 14 | 2020 | 502 | 3.620 |
Why?
|
| Monocytes | 14 | 2025 | 335 | 3.270 |
Why?
|
| Obesity | 20 | 2020 | 2426 | 2.410 |
Why?
|
| CD11c Antigen | 11 | 2021 | 40 | 2.230 |
Why?
|
| Atherosclerosis | 10 | 2025 | 948 | 2.040 |
Why?
|
| Insulin Resistance | 13 | 2021 | 690 | 1.890 |
Why?
|
| Inflammation | 13 | 2020 | 1489 | 1.380 |
Why?
|
| T-Lymphocytes | 7 | 2019 | 1722 | 1.150 |
Why?
|
| Fatty Acids | 2 | 2020 | 377 | 1.020 |
Why?
|
| Hypercholesterolemia | 5 | 2020 | 230 | 0.940 |
Why?
|
| Foam Cells | 3 | 2025 | 21 | 0.930 |
Why?
|
| Diet, High-Fat | 7 | 2025 | 268 | 0.920 |
Why?
|
| Intra-Abdominal Fat | 3 | 2017 | 61 | 0.900 |
Why?
|
| Panniculitis | 3 | 2016 | 20 | 0.880 |
Why?
|
| STAT1 Transcription Factor | 2 | 2020 | 81 | 0.790 |
Why?
|
| Apolipoproteins E | 7 | 2017 | 187 | 0.680 |
Why?
|
| Lipoprotein-X | 1 | 2020 | 3 | 0.650 |
Why?
|
| Diet, Western | 2 | 2019 | 20 | 0.640 |
Why?
|
| T-Lymphocyte Subsets | 3 | 2018 | 193 | 0.640 |
Why?
|
| CD8-Positive T-Lymphocytes | 4 | 2021 | 463 | 0.630 |
Why?
|
| Dietary Fats, Unsaturated | 1 | 2019 | 32 | 0.610 |
Why?
|
| Platelet Glycoprotein GPIIb-IIIa Complex | 4 | 2001 | 60 | 0.600 |
Why?
|
| Macrophages | 3 | 2018 | 667 | 0.590 |
Why?
|
| CD18 Antigens | 5 | 2017 | 42 | 0.580 |
Why?
|
| Weight Loss | 4 | 2011 | 538 | 0.570 |
Why?
|
| Hypertriglyceridemia | 3 | 2017 | 117 | 0.570 |
Why?
|
| Myositis | 2 | 2017 | 84 | 0.560 |
Why?
|
| Lymphocyte Activation | 3 | 2021 | 633 | 0.560 |
Why?
|
| Mice, Inbred C57BL | 21 | 2025 | 4738 | 0.550 |
Why?
|
| Mice, Knockout | 18 | 2025 | 3819 | 0.530 |
Why?
|
| Immunity | 1 | 2018 | 178 | 0.530 |
Why?
|
| Fatty Acids, Unsaturated | 1 | 2017 | 67 | 0.510 |
Why?
|
| Muscle, Skeletal | 4 | 2017 | 981 | 0.510 |
Why?
|
| Muscle Fibers, Skeletal | 2 | 2017 | 99 | 0.510 |
Why?
|
| Metabolic Diseases | 2 | 2018 | 143 | 0.500 |
Why?
|
| Cytokines | 3 | 2020 | 1339 | 0.500 |
Why?
|
| Animals | 33 | 2025 | 33912 | 0.500 |
Why?
|
| Eicosapentaenoic Acid | 1 | 2017 | 82 | 0.490 |
Why?
|
| Proprotein Convertase 9 | 1 | 2017 | 108 | 0.490 |
Why?
|
| Lipid Metabolism | 1 | 2019 | 387 | 0.480 |
Why?
|
| Dietary Supplements | 1 | 2020 | 448 | 0.480 |
Why?
|
| Mice | 27 | 2025 | 18301 | 0.470 |
Why?
|
| Chemotaxis, Leukocyte | 2 | 2013 | 68 | 0.470 |
Why?
|
| Hyperlipoproteinemia Type II | 1 | 2017 | 119 | 0.460 |
Why?
|
| Antigens, CD | 5 | 2001 | 410 | 0.460 |
Why?
|
| Cholesterol, VLDL | 1 | 2015 | 17 | 0.460 |
Why?
|
| Blood Platelets | 5 | 2016 | 313 | 0.450 |
Why?
|
| Triglycerides | 4 | 2017 | 602 | 0.440 |
Why?
|
| Membrane Glycoproteins | 5 | 2001 | 405 | 0.430 |
Why?
|
| Anticholesteremic Agents | 1 | 2017 | 239 | 0.430 |
Why?
|
| Liver | 6 | 2012 | 1796 | 0.420 |
Why?
|
| Immunity, Mucosal | 1 | 2014 | 95 | 0.420 |
Why?
|
| CD36 Antigens | 4 | 2019 | 35 | 0.410 |
Why?
|
| Aorta | 3 | 2020 | 521 | 0.410 |
Why?
|
| Flow Cytometry | 6 | 2020 | 765 | 0.410 |
Why?
|
| CD11a Antigen | 1 | 2013 | 11 | 0.410 |
Why?
|
| Aging | 2 | 2018 | 1242 | 0.400 |
Why?
|
| Interleukins | 1 | 2014 | 122 | 0.400 |
Why?
|
| Dietary Fats | 4 | 2014 | 278 | 0.400 |
Why?
|
| Aortic Diseases | 1 | 2015 | 190 | 0.380 |
Why?
|
| Lipoproteins, VLDL | 1 | 2012 | 53 | 0.360 |
Why?
|
| Disease Models, Animal | 9 | 2020 | 4697 | 0.360 |
Why?
|
| CD11b Antigen | 3 | 2009 | 33 | 0.350 |
Why?
|
| Antibodies, Monoclonal | 5 | 2001 | 981 | 0.350 |
Why?
|
| CD11 Antigens | 2 | 2017 | 11 | 0.340 |
Why?
|
| Integrin alpha Chains | 2 | 2017 | 15 | 0.340 |
Why?
|
| Phenotype | 2 | 2020 | 4497 | 0.340 |
Why?
|
| Dendritic Cells | 3 | 2021 | 439 | 0.330 |
Why?
|
| Receptor, Cannabinoid, CB1 | 1 | 2010 | 25 | 0.320 |
Why?
|
| Anti-Obesity Agents | 1 | 2010 | 47 | 0.320 |
Why?
|
| Endothelium, Vascular | 3 | 2021 | 468 | 0.290 |
Why?
|
| Piperidines | 1 | 2010 | 223 | 0.280 |
Why?
|
| Leukocytes | 1 | 2009 | 205 | 0.280 |
Why?
|
| Adiponectin | 2 | 2013 | 123 | 0.270 |
Why?
|
| Pyrazoles | 1 | 2010 | 349 | 0.260 |
Why?
|
| Humans | 31 | 2025 | 131163 | 0.260 |
Why?
|
| Hyperlipidemias | 2 | 2025 | 185 | 0.260 |
Why?
|
| Cells, Cultured | 5 | 2021 | 2885 | 0.250 |
Why?
|
| Cardiovascular Diseases | 1 | 2020 | 2121 | 0.250 |
Why?
|
| Chemokine CCL5 | 1 | 2007 | 53 | 0.250 |
Why?
|
| HIV Infections | 1 | 2019 | 2049 | 0.250 |
Why?
|
| Diabetes Mellitus | 1 | 2014 | 889 | 0.250 |
Why?
|
| Adipocytes | 4 | 2020 | 178 | 0.240 |
Why?
|
| Chemokine CCL2 | 3 | 2011 | 112 | 0.240 |
Why?
|
| Inflammation Mediators | 4 | 2017 | 226 | 0.230 |
Why?
|
| Weight Gain | 3 | 2013 | 393 | 0.220 |
Why?
|
| Body Weight | 1 | 2009 | 987 | 0.220 |
Why?
|
| Vascular Cell Adhesion Molecule-1 | 4 | 2020 | 72 | 0.220 |
Why?
|
| Male | 20 | 2025 | 64957 | 0.220 |
Why?
|
| Apolipoprotein C-III | 1 | 2025 | 46 | 0.220 |
Why?
|
| Oligonucleotides, Antisense | 1 | 2025 | 70 | 0.210 |
Why?
|
| Superantigens | 1 | 2004 | 20 | 0.210 |
Why?
|
| Adiposity | 2 | 2018 | 209 | 0.210 |
Why?
|
| Platelet Activation | 3 | 1999 | 64 | 0.210 |
Why?
|
| Neoplasms | 1 | 2019 | 3016 | 0.200 |
Why?
|
| Listeriosis | 1 | 2003 | 20 | 0.200 |
Why?
|
| Gene Knockdown Techniques | 1 | 2025 | 378 | 0.200 |
Why?
|
| Th1 Cells | 2 | 2021 | 158 | 0.180 |
Why?
|
| Interferon-gamma | 4 | 2021 | 544 | 0.180 |
Why?
|
| Spleen | 2 | 2018 | 258 | 0.180 |
Why?
|
| CD4-Positive T-Lymphocytes | 2 | 2015 | 500 | 0.170 |
Why?
|
| Lipoproteins, LDL | 2 | 2019 | 119 | 0.170 |
Why?
|
| Receptors, Fc | 1 | 2001 | 29 | 0.170 |
Why?
|
| Interleukin-5 | 1 | 2020 | 49 | 0.160 |
Why?
|
| Metabolic Syndrome | 3 | 2016 | 369 | 0.160 |
Why?
|
| Receptors, LDL | 2 | 2025 | 106 | 0.160 |
Why?
|
| Time Factors | 4 | 2015 | 6196 | 0.160 |
Why?
|
| Non-ST Elevated Myocardial Infarction | 1 | 2020 | 20 | 0.160 |
Why?
|
| Integrin alpha4beta1 | 2 | 2020 | 26 | 0.160 |
Why?
|
| Kupffer Cells | 1 | 2020 | 20 | 0.160 |
Why?
|
| Platelet Aggregation | 2 | 1999 | 100 | 0.150 |
Why?
|
| Receptors, Calcitriol | 1 | 2020 | 60 | 0.150 |
Why?
|
| Hepatitis | 1 | 2020 | 56 | 0.150 |
Why?
|
| Activating Transcription Factor 2 | 1 | 2019 | 16 | 0.150 |
Why?
|
| Membrane Microdomains | 2 | 2016 | 60 | 0.140 |
Why?
|
| Models, Immunological | 1 | 2018 | 36 | 0.140 |
Why?
|
| Blotting, Western | 1 | 2020 | 1013 | 0.140 |
Why?
|
| CD47 Antigen | 1 | 2018 | 8 | 0.140 |
Why?
|
| Adoptive Transfer | 3 | 2014 | 235 | 0.140 |
Why?
|
| Bone Marrow Transplantation | 1 | 2021 | 589 | 0.140 |
Why?
|
| Postprandial Period | 2 | 2016 | 93 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2020 | 1205 | 0.140 |
Why?
|
| Signal Transduction | 2 | 2021 | 4686 | 0.140 |
Why?
|
| Protein Kinases | 1 | 2019 | 312 | 0.130 |
Why?
|
| Adaptive Immunity | 1 | 2018 | 101 | 0.130 |
Why?
|
| Toll-Like Receptor 4 | 2 | 2015 | 142 | 0.130 |
Why?
|
| Receptors, CCR2 | 1 | 2017 | 23 | 0.130 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 1591 | 0.130 |
Why?
|
| Cell Line | 3 | 2020 | 2552 | 0.130 |
Why?
|
| Blood Vessels | 1 | 2017 | 92 | 0.130 |
Why?
|
| RNA, Messenger | 3 | 2009 | 2550 | 0.120 |
Why?
|
| Lipid Droplets | 1 | 2017 | 51 | 0.120 |
Why?
|
| Fatty Acids, Omega-3 | 1 | 2017 | 80 | 0.120 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2018 | 236 | 0.120 |
Why?
|
| Drug Combinations | 1 | 2017 | 270 | 0.120 |
Why?
|
| Glycosphingolipids | 1 | 2016 | 12 | 0.120 |
Why?
|
| Cell Movement | 2 | 2017 | 876 | 0.120 |
Why?
|
| Glucose | 2 | 2020 | 853 | 0.120 |
Why?
|
| Female | 13 | 2020 | 70963 | 0.120 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 2016 | 43 | 0.120 |
Why?
|
| Drugs, Chinese Herbal | 1 | 1996 | 20 | 0.120 |
Why?
|
| Calcium | 3 | 2001 | 1010 | 0.120 |
Why?
|
| Macrophages, Peritoneal | 1 | 2016 | 38 | 0.120 |
Why?
|
| Receptors, Ghrelin | 1 | 2016 | 30 | 0.120 |
Why?
|
| Carrier Proteins | 1 | 2021 | 993 | 0.120 |
Why?
|
| Blood Glucose | 3 | 2021 | 1117 | 0.110 |
Why?
|
| Up-Regulation | 4 | 2017 | 825 | 0.110 |
Why?
|
| Macrophage Activation | 2 | 2020 | 67 | 0.110 |
Why?
|
| Cholesterol, Dietary | 1 | 2015 | 49 | 0.110 |
Why?
|
| Glucose Intolerance | 2 | 2021 | 80 | 0.110 |
Why?
|
| Age Factors | 2 | 2018 | 2825 | 0.110 |
Why?
|
| Non-alcoholic Fatty Liver Disease | 1 | 2020 | 402 | 0.110 |
Why?
|
| Plaque, Atherosclerotic | 1 | 2016 | 150 | 0.110 |
Why?
|
| Cell Adhesion | 2 | 2015 | 308 | 0.100 |
Why?
|
| Osteonectin | 1 | 2013 | 7 | 0.100 |
Why?
|
| Lymphopenia | 1 | 2014 | 33 | 0.100 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2014 | 45 | 0.100 |
Why?
|
| Mice, Obese | 1 | 2013 | 74 | 0.100 |
Why?
|
| Cholesterol, LDL | 1 | 2017 | 604 | 0.100 |
Why?
|
| Coronary Artery Disease | 1 | 2020 | 887 | 0.100 |
Why?
|
| Interleukin-18 | 1 | 2013 | 75 | 0.100 |
Why?
|
| Interleukin-17 | 1 | 2014 | 125 | 0.100 |
Why?
|
| Interleukin-12 | 1 | 2013 | 125 | 0.100 |
Why?
|
| Cell Proliferation | 3 | 2018 | 2465 | 0.100 |
Why?
|
| Th17 Cells | 1 | 2014 | 101 | 0.100 |
Why?
|
| Adult | 6 | 2020 | 31282 | 0.090 |
Why?
|
| Palmitic Acid | 1 | 2012 | 27 | 0.090 |
Why?
|
| Gene Expression Regulation | 1 | 2020 | 2323 | 0.090 |
Why?
|
| Injections, Intravenous | 1 | 2012 | 239 | 0.090 |
Why?
|
| Diabetes, Gestational | 1 | 2013 | 112 | 0.090 |
Why?
|
| Case-Control Studies | 3 | 2020 | 3359 | 0.090 |
Why?
|
| Diet, Fat-Restricted | 1 | 2011 | 37 | 0.090 |
Why?
|
| Metalloendopeptidases | 1 | 2011 | 101 | 0.090 |
Why?
|
| Fibrinolytic Agents | 1 | 1993 | 182 | 0.090 |
Why?
|
| Thrombosis | 1 | 2016 | 499 | 0.080 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2013 | 639 | 0.080 |
Why?
|
| Insulin | 2 | 2013 | 1149 | 0.080 |
Why?
|
| Dyslipidemias | 1 | 2013 | 256 | 0.080 |
Why?
|
| Prognosis | 1 | 2020 | 4886 | 0.080 |
Why?
|
| Caloric Restriction | 1 | 2011 | 107 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2021 | 1459 | 0.080 |
Why?
|
| E-Selectin | 1 | 2009 | 38 | 0.070 |
Why?
|
| Chemokines | 1 | 2009 | 126 | 0.070 |
Why?
|
| Diet, Reducing | 1 | 2009 | 92 | 0.070 |
Why?
|
| Fatty Liver | 1 | 2011 | 224 | 0.070 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2009 | 111 | 0.070 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1939 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 787 | 0.070 |
Why?
|
| Energy Intake | 1 | 2010 | 502 | 0.070 |
Why?
|
| Protein Conformation | 2 | 1999 | 732 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2012 | 791 | 0.060 |
Why?
|
| Chemotactic Factors | 1 | 2007 | 15 | 0.060 |
Why?
|
| Receptors, CCR5 | 1 | 2007 | 30 | 0.060 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2020 | 14 | 0.060 |
Why?
|
| CD3 Complex | 1 | 2007 | 96 | 0.060 |
Why?
|
| Cell Differentiation | 3 | 2014 | 1928 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2009 | 1447 | 0.060 |
Why?
|
| Diet | 2 | 2010 | 1121 | 0.060 |
Why?
|
| Chemokines, CC | 1 | 2005 | 25 | 0.060 |
Why?
|
| Aged | 3 | 2020 | 21025 | 0.060 |
Why?
|
| 3T3-L1 Cells | 2 | 2015 | 54 | 0.050 |
Why?
|
| Ionomycin | 1 | 2004 | 15 | 0.050 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 2004 | 56 | 0.050 |
Why?
|
| Enterotoxins | 1 | 2004 | 77 | 0.050 |
Why?
|
| Listeria monocytogenes | 1 | 2003 | 30 | 0.050 |
Why?
|
| Colony Count, Microbial | 1 | 2003 | 86 | 0.050 |
Why?
|
| Immunophenotyping | 1 | 2004 | 332 | 0.050 |
Why?
|
| Cytotoxicity, Immunologic | 1 | 2004 | 272 | 0.050 |
Why?
|
| Middle Aged | 3 | 2020 | 28601 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2003 | 246 | 0.050 |
Why?
|
| In Vitro Techniques | 1 | 2003 | 808 | 0.050 |
Why?
|
| Killer Cells, Natural | 1 | 2004 | 355 | 0.040 |
Why?
|
| Neutrophils | 1 | 2003 | 371 | 0.040 |
Why?
|
| Receptors, Leptin | 1 | 2021 | 40 | 0.040 |
Why?
|
| Antigen Presentation | 1 | 2021 | 110 | 0.040 |
Why?
|
| Hyperinsulinism | 1 | 2021 | 58 | 0.040 |
Why?
|
| Transendothelial and Transepithelial Migration | 1 | 2020 | 7 | 0.040 |
Why?
|
| Immunity, Innate | 1 | 2003 | 406 | 0.040 |
Why?
|
| Receptors, Interferon | 1 | 2020 | 19 | 0.040 |
Why?
|
| Lab-On-A-Chip Devices | 1 | 2020 | 19 | 0.040 |
Why?
|
| Allosteric Regulation | 1 | 2020 | 57 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 2001 | 113 | 0.040 |
Why?
|
| Biomarkers | 1 | 2009 | 3385 | 0.040 |
Why?
|
| Cell Degranulation | 1 | 1999 | 27 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2020 | 274 | 0.040 |
Why?
|
| Biological Transport, Active | 2 | 1996 | 70 | 0.040 |
Why?
|
| Transplantation, Homologous | 1 | 2021 | 670 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 978 | 0.040 |
Why?
|
| RNA Interference | 1 | 2020 | 491 | 0.040 |
Why?
|
| Adolescent | 1 | 2017 | 20987 | 0.040 |
Why?
|
| Mice, Transgenic | 2 | 2016 | 2326 | 0.040 |
Why?
|
| Talin | 1 | 2018 | 10 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2021 | 801 | 0.030 |
Why?
|
| Cell Membrane | 1 | 2020 | 450 | 0.030 |
Why?
|
| Vitamin D | 1 | 2020 | 194 | 0.030 |
Why?
|
| Acute Disease | 1 | 2021 | 1153 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2020 | 1319 | 0.030 |
Why?
|
| Endothelial Cells | 1 | 2020 | 523 | 0.030 |
Why?
|
| Peritonitis | 1 | 2017 | 75 | 0.030 |
Why?
|
| Binding Sites | 1 | 1999 | 1133 | 0.030 |
Why?
|
| Coronary Vessels | 1 | 2020 | 521 | 0.030 |
Why?
|
| Percutaneous Coronary Intervention | 1 | 2020 | 299 | 0.030 |
Why?
|
| Cricetulus | 1 | 2016 | 90 | 0.030 |
Why?
|
| Homeostasis | 1 | 2020 | 712 | 0.030 |
Why?
|
| CHO Cells | 1 | 2016 | 152 | 0.030 |
Why?
|
| Hormone Antagonists | 1 | 2016 | 43 | 0.030 |
Why?
|
| RAW 264.7 Cells | 1 | 2016 | 49 | 0.030 |
Why?
|
| Paxillin | 1 | 2015 | 13 | 0.030 |
Why?
|
| Focal Adhesions | 1 | 2015 | 14 | 0.030 |
Why?
|
| Antigens, Ly | 1 | 2015 | 31 | 0.030 |
Why?
|
| Graft vs Host Disease | 1 | 2021 | 694 | 0.030 |
Why?
|
| Platelet Membrane Glycoproteins | 1 | 1995 | 29 | 0.030 |
Why?
|
| Lipolysis | 1 | 2016 | 83 | 0.030 |
Why?
|
| Transcriptional Activation | 1 | 2017 | 419 | 0.030 |
Why?
|
| Microfluidics | 1 | 2015 | 31 | 0.030 |
Why?
|
| Energy Metabolism | 1 | 2020 | 804 | 0.030 |
Why?
|
| Cell Plasticity | 1 | 2016 | 42 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2015 | 101 | 0.030 |
Why?
|
| Calcium-Binding Proteins | 1 | 2016 | 325 | 0.030 |
Why?
|
| von Willebrand Factor | 1 | 2016 | 191 | 0.030 |
Why?
|
| Enzyme Activation | 1 | 2015 | 576 | 0.030 |
Why?
|
| Microfilament Proteins | 1 | 2016 | 269 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2016 | 299 | 0.030 |
Why?
|
| Proinsulin | 1 | 2013 | 13 | 0.030 |
Why?
|
| Epitopes | 1 | 1995 | 324 | 0.030 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 1 | 2014 | 59 | 0.030 |
Why?
|
| Culture Media, Conditioned | 1 | 2014 | 81 | 0.030 |
Why?
|
| Antibodies, Blocking | 1 | 2014 | 47 | 0.030 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 1996 | 267 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2009 | 12936 | 0.030 |
Why?
|
| Body Mass Index | 2 | 2013 | 1717 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 301 | 0.020 |
Why?
|
| Myeloid Differentiation Factor 88 | 1 | 2014 | 93 | 0.020 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 1993 | 32 | 0.020 |
Why?
|
| DNA, Recombinant | 1 | 1993 | 71 | 0.020 |
Why?
|
| Autoimmunity | 1 | 2014 | 175 | 0.020 |
Why?
|
| Fibroblast Growth Factors | 1 | 2013 | 172 | 0.020 |
Why?
|
| Fasting | 1 | 2013 | 303 | 0.020 |
Why?
|
| Diabetes Complications | 1 | 2013 | 197 | 0.020 |
Why?
|
| Protein Binding | 1 | 2016 | 1652 | 0.020 |
Why?
|
| Tissue Plasminogen Activator | 1 | 1993 | 104 | 0.020 |
Why?
|
| Interleukin-6 | 1 | 2014 | 412 | 0.020 |
Why?
|
| Hyperglycemia | 1 | 2014 | 234 | 0.020 |
Why?
|
| ADAMTS13 Protein | 1 | 2011 | 64 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 1993 | 552 | 0.020 |
Why?
|
| Comorbidity | 1 | 2016 | 1595 | 0.020 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-1 | 1 | 2010 | 35 | 0.020 |
Why?
|
| Biological Transport | 1 | 2010 | 329 | 0.020 |
Why?
|
| Gestational Age | 1 | 2013 | 1224 | 0.020 |
Why?
|
| Lipoproteins | 1 | 2010 | 183 | 0.020 |
Why?
|
| Gene Expression | 1 | 2013 | 1481 | 0.020 |
Why?
|
| Sex Factors | 1 | 2011 | 1356 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2014 | 1801 | 0.020 |
Why?
|
| Chemokine CCL11 | 1 | 2005 | 12 | 0.010 |
Why?
|
| 3T3 Cells | 1 | 2005 | 117 | 0.010 |
Why?
|
| Species Specificity | 1 | 2005 | 470 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2013 | 3829 | 0.010 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2016 | 3436 | 0.010 |
Why?
|
| Body Composition | 1 | 2005 | 545 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 517 | 0.010 |
Why?
|
| Pregnancy | 1 | 2013 | 7512 | 0.010 |
Why?
|